Ergoteles’s Ibere Pharmaceuticals Units IBER.U Stock Holding History
Bought
Maintained
Sold
Other funds holding IBER.U
Ergoteles's IBER.U Position: Q4 2022 in Review
Ergoteles sold out of Ibere Pharmaceuticals Units (IBER.U) in Q4 2022, closing a stake of 13,850 shares — an estimated $137K sold.
Ergoteles first reported a position in IBER.U in Q1 2021 and held it in 7 quarters. The position peaked at $139K in Q4 2021. 10 funds tracked by Wall St. Rank hold IBER.U as of Q4 2022.
- Ergoteles reported no remaining Ibere Pharmaceuticals Units position as of Q4 2022 after selling out during the quarter.
- Ergoteles sold 13,850 Ibere Pharmaceuticals Units shares in Q4 2022, an estimated $137K.
- Ergoteles first reported a position in Ibere Pharmaceuticals Units in Q1 2021 and held it in 7 quarters.
- Ergoteles's Ibere Pharmaceuticals Units position peaked at $139K in Q4 2021.
- 10 funds tracked by Wall St. Rank held Ibere Pharmaceuticals Units as of Q4 2022.
Based on Ergoteles's 13F filing for Q4 2022, filed 14 Feb 2023.